Novo Nordisk
Sector: Healthcare
Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark. Founded in 1923, it is a global leader in diabetes care and treatments for obesity and other chronic diseases. The company focuses on the research, development, manufacturing, and distribution of pharmaceutical products, with key therapeutic areas including diabetes, obesity, rare diseases, cardiovascular conditions, and endocrine disorders. Novo Nordisk is known for its insulin products and GLP-1-based therapies and operates in more than 160 countries, emphasizing innovation, sustainability, and patient-centered healthcare.
We are tracking 1 layoff event for Novo Nordisk as of Sep 10, 2025.